BE THE NEW

Global Product Manager of Rare Disease (SBS)

in a biotech company focused on the discovery, design and development of innovative peptide-based medicines

We are looking for a new Global Product Manager of Rare Disease – Short Bowel Syndrome (SBS) who has extensive Commercial experience leading across multiple functions with complementary expertise in marketing for rare diseases in the United States.

If this sounds like you, and you are ready to take on a broad area of responsibilities with an independent attitude, then keep reading.

In collaboration with the commercial team, you will play a key role and be accountable for creating and supporting implementation of the product strategy and launch plans including but not limited to building disease and product marketing plans for patients and HCPs. Translating brand strategy into robust omnichannel engagement and patient support to optimize product onboarding and adherence. Drive tactical development and execution of branded materials including website content creation, promotional material development, patient education tools, congress planning and execution, agency management, HCP and patient market research, and promotional material review process. The initial focus is US but may also contain more global content, such as Europe and ROW.

This is a unique opportunity to join us at a time of exciting growth. The patient is at the heart of what we do and your expertise will be key to our success in launching new innovative treatments to underserved patients. This is a very visible, hands-on role interfacing with multiple cross-functional teams and has significant opportunity to create long term impact throughout our organization with structured marketing capabilities and structured collaboration. The majority of the Product Manager’s time will be spent in the Copenhagen, DK office.

You will report to our Sr. Director, Head of Marketing SBS, who reports directly to the VP of Commercial.

Responsibilities

Maintain a comprehensive and up-to-date understanding of US HCP and COE landscape for SBS, with a view to support launch activities to ensure better patient support in this rare disease space
Support the commercial team in the development of a global launch strategy and required pre-market development activities and market research
Establish an HCP, Patient and Omnichannel brand plan with tactical elements in collaboration with cross-functional project teams within the organization.
Identify market research requirements and lead projects with external partners
Work with team members to maintain a comprehensive and up-to-date understanding of the competitive environment and continuously assess potential impact on current markets.
Support the commercial team in the development of a global launch strategy and required pre-market development activities and market research
Represent the Commercial marketing function in project review committee meetings (MLR, joint project teams, field facing meetings).
Presenting to and training field staff.
Review and analyze market & sales data objectively to highlight opportunities and risks.
In collaboration with the Sr. Director, maintain budget responsibilities and aid in preparation of yearly budget.
Work with team members to maintain a comprehensive and up-to-date understanding of the competitive environment and continuously assess potential impact on current markets.

Candidate profile

Degree in life sciences or business; advanced degree preferred (e.g. MBA).
Experience in the pharmaceutical or biotech industry with 5+ years of Commercial experience across multiple functions.
Solid understanding of US marketing, including promotional regulatory environment
Rare disease experience including patient and omnichannel strategy development and tactical pull through
Recognized leadership skills in direct and matrixed environments and the ability to align different parts of the organization to enable effective decision making.
Demonstrated ability to metabolize high-level strategic thinking into detailed operational implementation. This position will be called on to pivot between various commercial workstreams depending on the current business environment.
Demonstrated excellence in effective communication, influencing, and negotiation for a wide variety of audiences.
Ability to build strong collaborative relationships with project team members and executives and demonstrate the ability to assimilate and apply new knowledge rapidly.
Excellent oral and written English communication skills a must.

Bonding to innovate 

Our employees are fundamental to our success, and we continue to be able to attract and retain people with vast experience and talent. We have a unique culture, characterized by excellent teamwork and strong engagement across the organization.

Making bonds is at the core of everything we do. From discovering and developing the best new peptide drugs for patients, to engaging with our partners or connecting with each other.

We bond as a result of our entrepreneurial culture where our people are encouraged to pursue their ideas and turn them into reality. We are curious about each other’s knowledge and expertise.

We bond through curiosity and playfulness as a team, allowing ourselves to challenge common thinking and drive future innovation. Zealand Pharma is a place where everyone is heard and contributes to the success, we all want to experience.

The Zealand Pharma DNA builds on four values: (1) We are bold, (2) We empower people, (3) We work as one team, and (4) We can be trusted.

Let’s bond and be bold 

We offer a combined compensation package which includes a base salary, pension, bonus, and a possibility to join our employee share program. We care about our employees’ well-being and offer health insurance, use of massage, fitness, and a range of social clubs and activities.

To find out more about working at Zealand, visit https://www.zealandpharma.com/careers/zealand-as-a-workplace/

Interested? Please apply no later than October 2, 2024 or as soon as possible. The applications will be reviewed as they come in.

For further information, please contact Tracey Bateman at ext_tbateman@zealandpharma.com

About Zealand Pharma A/S

Zealand Pharma A/S (Nasdaq Copenhagen: ZEAL) ("Zealand") is a Danish biotechnology company on a mission to change lives with next generation peptide medicines. In our effort to reach our goals bonding is at the core of everything we do. Let it be discovering and developing the best new peptide drugs for patients, engaging with partners or connecting with each other. This has led to more than 10 drug candidates invented by Zealand having advanced into clinical development, of which two have reached the market. Zealand’s current pipeline of internal product candidates focus on specialty gastrointestinal and metabolic diseases. Additionally, the portfolio includes clinical license collaboration with Boehringer Ingelheim and pre-clinical license collaboration with Alexion Pharmaceuticals. Zealand is based in Copenhagen (Søborg), Denmark. For further information about the Company's business and activities, please visit www.zealandpharma.com or bond with us through LinkedIn.

About Short Bowel Syndrome – Intestinal Failure

Short bowel syndrome (SBS) is a complex disease that occurs due to the physical loss of half or more of the small intestine, most often due to surgical removal. As a result, individuals with SBS often have a reduced ability to absorb nutrients and fluids. In more severe cases, referred to as SBS with intestinal failure (SBS-IF), patients are dependent on complex parenteral support (PS) to sustain life. PS is a way to receive nutrients by bypassing the digestive system through an intravenous catheter.

SBS with intestinal failure is associated with significant medical complications, including liver and renal failure, metabolic complications, chronic fatigue, and life-threatening infections. Although lifesaving, management of PS is associated with a significant burden on healthcare systems and reduction in quality of life for patients and their families.